https://www.geminalabs.com/news/corporate-update 2025-11-07 https://www.geminalabs.com/news/change-to-board 2025-11-04 https://www.geminalabs.com/news/private-placement 2025-11-04 https://www.geminalabs.com/news/gemina-laboratories-announces-termination-of-transaction 2025-11-04 https://www.geminalabs.com/news/gemina-laboratories-strategic-update%3A-accelerating-commercialisation 2025-11-04 https://www.geminalabs.com/news/listing-announcement 2024-06-20 https://www.geminalabs.com/news/addition-to-ip-portfolio 2025-11-04 https://www.geminalabs.com/news/first-strategic-license-deal 2025-11-04 https://www.geminalabs.com/news/focusing-on-respiratory-infections-and-strategic-partnerships 2025-11-04 https://www.geminalabs.com/news/closing-of-financing 2025-11-04 https://www.geminalabs.com/news/stifel-as-advisor 2025-11-04 https://www.geminalabs.com/news/major-breakthrough-in-lateral-flow-test-design- 2025-11-04 https://www.geminalabs.com/news/participation-at-aacc 2025-11-04 https://www.geminalabs.com/news/tb-diagnosis-in-saliva 2025-11-04 https://www.geminalabs.com/news/major-lateral-flow-performance-improvement 2025-11-04 https://www.geminalabs.com/news/closing-of-private-placement 2025-11-04 https://www.geminalabs.com/news/investor-webinar 2025-11-04 https://www.geminalabs.com/news/diagnostic-strategist-appointed-to-board 2025-11-04 https://www.geminalabs.com/news/healthcare-industry-leader-appointed-to-board 2025-11-04 https://www.geminalabs.com/news/appointment-of-vp-for-strategy 2025-11-04 https://www.geminalabs.com/news/strategic-update---january-2023 2025-11-04 https://www.geminalabs.com/news/influenza-a%2Fb-diagnostic-test-prototype-completed 2025-11-04 https://www.geminalabs.com/news/chair-of-clinical-advisory-board-appointment 2025-11-04 https://www.geminalabs.com/news/ubc-research-collaboration 2025-11-04 https://www.geminalabs.com/news/investment-sees-immediate-progress 2025-11-04 https://www.geminalabs.com/news/stake-in-rapivd 2025-11-04 https://www.geminalabs.com/news/license-and-manufacturing-agreements 2025-11-04 https://www.geminalabs.com/news/participation-at-h.c.-wainwright-investment-conference 2025-11-04 https://www.geminalabs.com/news/brian-firth-appointed-ceo 2025-11-04 https://www.geminalabs.com/news/closing-of-concurrent-private-placement 2025-11-04 https://www.geminalabs.com/news/closing-of-raise 2025-11-04 https://www.geminalabs.com/news/prospectus-supplement 2025-11-04 https://www.geminalabs.com/news/proposed-financing-up-to-%245m 2025-11-04 https://www.geminalabs.com/news/appointment-of-brian-firth-as-advisor 2025-11-04 https://www.geminalabs.com/news/ce-mark-approval 2023-01-27 https://www.geminalabs.com/news/completion-of-trials 2023-01-27 https://www.geminalabs.com/news/patient-testing-nears-completion 2023-01-27 https://www.geminalabs.com/news/technical-and-ip-update 2023-01-27 https://www.geminalabs.com/news/strategic-update---technology-roadmap 2023-01-27 https://www.geminalabs.com/news/establishment-of-uk-subsidiary-and-appointment-of-head-of-productization 2023-01-27 https://www.geminalabs.com/news/covid-development-completion 2023-01-27 https://www.geminalabs.com/news/senior-scientific-advisor-appointment 2023-01-27 https://www.geminalabs.com/news/closure-of-private-placement 2023-01-27 https://www.geminalabs.com/news/private-placement 2023-01-27 https://www.geminalabs.com/news/initial-covid-results 2023-01-27 https://www.geminalabs.com/news/corporate-update 2025-11-07 https://www.geminalabs.com/news/research-and-development-appointments 2023-01-27 https://www.geminalabs.com/news/listing-announcement-cse 2025-11-04